journal article·2020-01-01Open access

Concentrated growth factor promotes gingival regeneration through the AKT/Wnt/β-catenin and YAP signaling pathways

Lei Qi, Lu Liu, Yue Hu, Jie Li, Jiayi Li, Ningning Cao, Fangxing Zhu, Chaoji Shi, Lei Zhang

Abstract

Although concentrated growth factor (CGF) is known to promote gingival regeneration and improve the outcomes of clinical treatment, the mechanisms underlying its effects remain unknown. Therefore, this study aimed to elucidate the effects of CGF on gingival thickening. To this end, gingival mesenchymal stem cells (GMSCs) were treated with different concentrations of CGF, and the effects of CGF on cell proliferation and migration; collagen-1 (Col-1), fibronectin (FN), vascular endothelial growth factor (VEGF), and angiopoietin-1 (Ang-1) expression; and the AKT, Wnt/β-catenin, and Yes-associated protein (YAP) signalling pathways were investigated. The effects of CGF in vivo were also investigated in a rat buccal gingival injection model. GMSCs cultured with CGF showed improved cell proliferation and migration. Moreover, CGF treatment improved the levels of FN, Col-1, VEGF, and ANG-1. These effects of CGF were mediated by the AKT/Wnt and YAP pathways, with the AKT pathway possibly functioning upstream of the Wnt/β-catenin and YAP pathways. YAP was also shown to be overexpressed in the in vivo model. Thus, CGF can promote gingival regeneration, and YAP transport into the nucleus may be a key factor underlying this activity, which provides a novel perspective for gingival regeneration and further promotion of the clinical application of CGF.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Periodontal Regeneration and Treatments · dental development and anomalies · Oral and Maxillofacial Pathology

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Oral and Cranio-Maxillofacial Surgery, Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine

National Clinical Research Center for Oral Diseases, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine

Shanghai Key Laboratory of Stomatology and Shanghai Research Institute of Stomatology, Shanghai Jiao Tong University School of Medicine

Department of Oral and Maxillofacial-Head Neck Oncology, Shanghai Ninth People’s Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine

Funding

Clinical Research Programme of 9th people’s Hospital affiliated to Shanghai Jiao Tong University School of Medicine · Shanghai’s Top Priority Clinical Medicine Centre

References (56)

Show source-provided references
1. 10.1002/JPER.18-012510.1002/JPER.18-0125 ↗
2. 10.1016/j.ajodo.2014.08.02110.1016/j.ajodo.2014.08.021 ↗
3. 10.11607/prd.392110.11607/prd.3921 ↗
4. 10.1590/1807-3107bor-2018.vol32.005510.1590/1807-3107bor-2018.vol32.0055 ↗
5. 10.4252/wjsc.v10.i9.11610.4252/wjsc.v10.i9.116 ↗
6. 10.1007/s00784-018-2706-510.1007/s00784-018-2706-5 ↗
7. 10.1111/iej.1304510.1111/iej.13045 ↗
8. 10.1007/s10047-013-0711-710.1007/s10047-013-0711-7 ↗
9. Chen X, Zhang R, Zhang Q, et al. Microtia patients: auricular chondrocyte ECM is promoted by CGF through IGF-1 activation of the IGF-1R/PI3K/AKT pathway. J Cell Physiol. 2018;10:88–98.
10. 10.1016/j.joen.2018.03.00610.1016/j.joen.2018.03.006 ↗
11. 10.1155/2018/459732110.1155/2018/4597321 ↗
12. 10.1902/jop.2015.15019810.1902/jop.2015.150198 ↗
13. 10.1016/j.tem.2018.04.00610.1016/j.tem.2018.04.006 ↗
14. 10.1016/j.ceb.2017.12.01210.1016/j.ceb.2017.12.012 ↗
15. 10.1007/978-1-4939-8910-2_2610.1007/978-1-4939-8910-2_26 ↗
16. 10.1038/s41569-018-0063-310.1038/s41569-018-0063-3 ↗
17. 10.1016/j.pharmthera.2017.12.01110.1016/j.pharmthera.2017.12.011 ↗
18. 10.1038/s41556-018-0142-z10.1038/s41556-018-0142-z ↗
19. 10.1016/j.celrep.2016.02.02110.1016/j.celrep.2016.02.021 ↗
20. 10.1038/s41413-018-0018-710.1038/s41413-018-0018-7 ↗
21. 10.3390/cells804034710.3390/cells8040347 ↗
22. 10.1038/s41388-018-0631-310.1038/s41388-018-0631-3 ↗
23. 10.1016/j.tcb.2018.03.00110.1016/j.tcb.2018.03.001 ↗
24. 10.1016/j.molcel.2016.05.01210.1016/j.molcel.2016.05.012 ↗
25. 10.7150/ijms.2511510.7150/ijms.25115 ↗
26. 10.1177/002203451349796110.1177/0022034513497961 ↗
27. 10.1615/CritRevEukaryotGeneExpr.201501253910.1615/CritRevEukaryotGeneExpr.2015012539 ↗
28. 10.1186/s13287-019-1324-810.1186/s13287-019-1324-8 ↗
29. 10.1155/2019/781032010.1155/2019/7810320 ↗
30. 10.7554/eLife.5340410.7554/eLife.53404 ↗
31. 10.4317/jced.5504910.4317/jced.55049 ↗
32. 10.2334/josnusd.17-037010.2334/josnusd.17-0370 ↗
33. 10.1002/JPER.16-067110.1002/JPER.16-0671 ↗
34. 10.1186/s12903-018-0635-y10.1186/s12903-018-0635-y ↗
35. 10.1016/j.ajodo.2018.01.00910.1016/j.ajodo.2018.01.009 ↗
36. 10.1002/JPER.17-038110.1002/JPER.17-0381 ↗
37. 10.1111/prd.1207010.1111/prd.12070 ↗
38. Regmi S, Pathak S, Kim JO, et al. Mesenchymal stem cell therapy for the treatment of inflammatory diseases: challenges, opportunities, and future perspectives. Eur J Cell Biol. 2019;33:14–23.
39. Li P, Gong Z, Shultz LD, et al. Mesenchymal stem cells: from regeneration to cancer. Pharmacol Ther. 2019;23:32–43.
40. 10.1089/wound.2015.066110.1089/wound.2015.0661 ↗
41. 10.1177/107385841453217110.1177/1073858414532171 ↗
42. 10.2174/1574888X1366618022014111410.2174/1574888X13666180220141114 ↗
43. 10.1016/j.biomaterials.2013.12.05310.1016/j.biomaterials.2013.12.053 ↗
44. 10.1016/j.biomaterials.2013.05.02510.1016/j.biomaterials.2013.05.025 ↗
45. Chen X, Chen YH, Hou Y. Modulation of proliferation and differentiation of gingiva derived mesenchymal stem cells by concentrated growth factors: potential implications in tissue engineering for dental regeneration and repair. Int J Mol Med. 2019;34:45–65.
46. 10.1111/jopr.1231610.1111/jopr.12316 ↗
47. 10.1016/j.tripleo.2005.07.01010.1016/j.tripleo.2005.07.010 ↗
48. Peixe GPG, Lourenço SIM, de Vasconcelos Gurgel BC. Immunohistochemical study of CD34 and podoplanin in periodontal disease. J Periodont. 2019;43:78–89.
49. Zhao N, Suzuki A, Zhang X, et al. Dual aptamer-functionalized in situ injectable fibrin hydrogel for promotion of angiogenesis via co-delivery of VEGF and PDGF-BB. ACS Appl Mater Interfaces. 2019;108:44–65.
50. 10.1039/C4BM00390J10.1039/C4BM00390J ↗
51. 10.1016/j.biomaterials.2019.04.01410.1016/j.biomaterials.2019.04.014 ↗
52. 10.1016/j.biopha.2019.10874610.1016/j.biopha.2019.108746 ↗
53. 10.1016/j.tibs.2017.09.00310.1016/j.tibs.2017.09.003 ↗
54. 10.1016/j.biomaterials.2018.11.00710.1016/j.biomaterials.2018.11.007 ↗
55. 10.1016/j.injury.2018.06.01110.1016/j.injury.2018.06.011 ↗
56. 10.1111/jocd.1295510.1111/jocd.12955 ↗